Galeterone Terminated Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01709734A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer